• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导针对硫酸化糖胺聚糖的抗抗独特型抗体可减少载脂蛋白 E 缺陷小鼠的动脉粥样硬化。

Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.

机构信息

Division of Immunobiology, Center of Molecular Immunology, 216 St and 15th Ave, Siboney, Playa PO Box 16040, Havana 11600, Cuba.

出版信息

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2847-54. doi: 10.1161/ATVBAHA.112.300444. Epub 2012 Oct 18.

DOI:10.1161/ATVBAHA.112.300444
PMID:23087361
Abstract

OBJECTIVE

The pathogenesis of atherosclerosis is associated with the early retention of low-density lipoproteins that are trapped in the extracellular matrix of the arterial intima by interaction with glycosaminoglycan side chains of proteoglycans. Mutant mouse/human chimeric antibodies of the murine monoclonal antibody P3, which react with N-glycolyl-containing gangliosides and sulfated glycosaminoglycans, were tested for their potentially antiatherogenic properties through the induction of an idiotypic antibody network that may specifically interfere with the binding of low-density lipoproteins to proteoglycan side chains, low-density lipoprotein modification, and foam cell formation.

METHODS AND RESULTS

Apolipoprotein E-deficient mice fed a high-fat, high-cholesterol diet received 5 to 6 doses of chP3R99 or chP3S98 mutant antibodies, showing high and low reactivity, respectively, against their respective antigens. Both chimeric antibodies elicited an immunodominant anti-idiotypic response in the absence of adjuvant. A striking (40%-43%) reduction (P<0.01) in total lesion areas was observed in 18-week-old mice immunized with chP3R99, but not chP3S98, compared with PBS-treated mice. The antiatherosclerotic effect was associated with increased mice sera reactivity against heparin and sulfated glycosaminoglycans, including chondroitin and dermatan sulfate. In addition, purified IgG from chP3R99-immunized mice blocked the retention of apolipoprotein B-containing lipoproteins within the arterial wall of apolipoprotein E(-/-) mice.

CONCLUSIONS

The present study supports use of active immunization and the mounting of an idiotypic antibody network response against glycosaminoglycans as a novel approach to target atherosclerosis.

摘要

目的

动脉粥样硬化的发病机制与低密度脂蛋白(LDL)的早期滞留有关,这些 LDL 通过与蛋白聚糖的糖胺聚糖侧链相互作用而滞留在动脉内膜的细胞外基质中。通过诱导可能特异性干扰 LDL 与蛋白聚糖侧链结合、LDL 修饰和泡沫细胞形成的独特型抗体网络,测试了反应性 N-羟乙酰神经氨酸糖脂和硫酸化糖胺聚糖的鼠单克隆抗体 P3 的突变体鼠/人嵌合抗体的潜在抗动脉粥样硬化特性。

方法和结果

喂食高脂肪、高胆固醇饮食的载脂蛋白 E 缺陷型小鼠接受了 5 至 6 次 chP3R99 或 chP3S98 突变体抗体的注射,这两种抗体分别对其相应抗原具有高和低的反应性。在没有佐剂的情况下,两种嵌合抗体都引发了免疫优势的抗独特型反应。与 PBS 处理的小鼠相比,用 chP3R99 免疫的 18 周龄小鼠的总病变面积显著减少(40%-43%,P<0.01),但 chP3S98 则没有。抗动脉粥样硬化作用与增加的小鼠血清对肝素和硫酸化糖胺聚糖(包括软骨素和硫酸皮肤素)的反应性有关。此外,从 chP3R99 免疫的小鼠中纯化的 IgG 阻断了载脂蛋白 B 载脂蛋白 E(-/-)小鼠动脉壁内脂蛋白的滞留。

结论

本研究支持使用主动免疫和针对糖胺聚糖的独特型抗体网络反应作为靶向动脉粥样硬化的新方法。

相似文献

1
Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.诱导针对硫酸化糖胺聚糖的抗抗独特型抗体可减少载脂蛋白 E 缺陷小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2847-54. doi: 10.1161/ATVBAHA.112.300444. Epub 2012 Oct 18.
2
Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans.结合细胞外基质糖胺聚糖的抗体的抗动脉粥样硬化作用。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):595-604. doi: 10.1161/ATVBAHA.111.238659. Epub 2012 Jan 19.
3
Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice.通过用抗糖胺聚糖单克隆抗体免疫载脂蛋白 E 缺陷小鼠来阻止进行性动脉粥样硬化。
Free Radic Biol Med. 2015 Dec;89:557-66. doi: 10.1016/j.freeradbiomed.2015.08.027. Epub 2015 Oct 8.
4
The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis.抗糖胺聚糖抗体治疗可降低动脉粥样硬化兔模型主动脉氧化应激。
Free Radic Res. 2013 Apr;47(4):309-15. doi: 10.3109/10715762.2013.772995. Epub 2013 Mar 5.
5
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.抗硫酸化糖胺聚糖嵌合单克隆抗体治疗对载脂蛋白E缺陷小鼠现存病变的动脉粥样硬化消退潜力
Front Pharmacol. 2017 Nov 1;8:782. doi: 10.3389/fphar.2017.00782. eCollection 2017.
6
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.用小鼠/人嵌合抗体靶向兔动脉粥样硬化中的动脉壁硫酸化糖胺聚糖。
MAbs. 2014;6(5):1340-6. doi: 10.4161/mabs.29970. Epub 2014 Oct 30.
7
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE Mice: Association with Atheroprotection.载脂蛋白E基因敲除小鼠中抗糖胺聚糖单克隆抗体对独特型级联反应的剂量依赖性诱导:与动脉粥样硬化保护作用的关联
Front Immunol. 2017 Mar 3;8:232. doi: 10.3389/fimmu.2017.00232. eCollection 2017.
8
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis.单克隆抗体 chP3R99 减少胰岛素抵抗大鼠动脉粥样硬化病变中致动脉粥样脂蛋白的血管内膜下滞留:作为动脉粥样硬化免疫原的急性治疗与长期保护
J Am Heart Assoc. 2024 Jul 2;13(13):e032419. doi: 10.1161/JAHA.123.032419. Epub 2024 Jun 27.
9
Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.血小板衍生生长因子和低密度脂蛋白与人动脉平滑肌细胞产生的糖胺聚糖种类的结合。
J Cell Physiol. 1995 May;163(2):380-92. doi: 10.1002/jcp.1041630218.
10
Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.慢性输注尾加压素II可增强载脂蛋白E基因敲除小鼠巨噬细胞泡沫细胞的形成及动脉粥样硬化。
J Hypertens. 2008 Oct;26(10):1955-65. doi: 10.1097/HJH.0b013e32830b61d8.

引用本文的文献

1
Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.动脉粥样硬化:从降脂和抗炎疗法到靶向含载脂蛋白B脂蛋白的动脉潴留
Front Immunol. 2025 Jun 9;16:1485801. doi: 10.3389/fimmu.2025.1485801. eCollection 2025.
2
A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction.动脉粥样硬化免疫治疗的文献计量分析:趋势与热点预测
Front Immunol. 2024 Nov 19;15:1493250. doi: 10.3389/fimmu.2024.1493250. eCollection 2024.
3
Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis.
调节动脉内膜中泡沫细胞形成的机制:探索动脉粥样硬化的新治疗机会。
Front Cardiovasc Med. 2024 Jun 17;11:1381520. doi: 10.3389/fcvm.2024.1381520. eCollection 2024.
4
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis.单克隆抗体 chP3R99 减少胰岛素抵抗大鼠动脉粥样硬化病变中致动脉粥样脂蛋白的血管内膜下滞留:作为动脉粥样硬化免疫原的急性治疗与长期保护
J Am Heart Assoc. 2024 Jul 2;13(13):e032419. doi: 10.1161/JAHA.123.032419. Epub 2024 Jun 27.
5
Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis.平滑肌细胞-蛋白聚糖-脂蛋白相互作用作为动脉粥样硬化的驱动因素。
Handb Exp Pharmacol. 2022;270:335-358. doi: 10.1007/164_2020_364.
6
Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.抗载脂蛋白 B-100 自身抗体是不稳定冠状动脉斑块的标志物。
J Atheroscler Thromb. 2021 Oct 1;28(10):1025-1034. doi: 10.5551/jat.58784. Epub 2020 Nov 15.
7
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.抗硫酸化糖胺聚糖嵌合单克隆抗体治疗对载脂蛋白E缺陷小鼠现存病变的动脉粥样硬化消退潜力
Front Pharmacol. 2017 Nov 1;8:782. doi: 10.3389/fphar.2017.00782. eCollection 2017.
8
Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis.血管介入诱导的内膜增生会导致脂蛋白潴留并加速动脉粥样硬化。
Physiol Rep. 2017 Jul;5(14). doi: 10.14814/phy2.13334.
9
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE Mice: Association with Atheroprotection.载脂蛋白E基因敲除小鼠中抗糖胺聚糖单克隆抗体对独特型级联反应的剂量依赖性诱导:与动脉粥样硬化保护作用的关联
Front Immunol. 2017 Mar 3;8:232. doi: 10.3389/fimmu.2017.00232. eCollection 2017.
10
2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.2016年罗素·罗斯血管生物学纪念讲座:动脉粥样硬化进展中的分子细胞机制
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):183-189. doi: 10.1161/ATVBAHA.116.308036. Epub 2016 Dec 15.